We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$85.2B
AUM Growth
+$4.83B
Cap. Flow
+$8.98B
Cap. Flow %
10.54%
Top 10 Hldgs %
12.02%
Holding
4,686
New
822
Increased
1,556
Reduced
1,625
Closed
650

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$786M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$409M
3
MU icon
Micron Technology
MU
+$379M
4
T icon
AT&T
T
+$372M
5
MDT icon
Medtronic
MDT
+$370M

Sector Composition

Rank Sector Weight
1 Healthcare 18.69%
2 Technology 14.95%
3 Consumer Discretionary 11.34%
4 Consumer Staples 10.7%
5 Communication Services 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AHI
3976
DELISTED
Advanced Health Intelligence Ltd
AHI
$29K ﹤0.01%
+4,750
New +$39.9K
BCDA icon
3977
BioCardia
BCDA
$13.8M
$28K ﹤0.01%
+913
New +$27.1K
QNTM
3978
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$20.8M
$28K ﹤0.01%
502
+297
+145% +$18K
VYNT
3979
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$28K ﹤0.01%
3,882
-15,386
-80% -$89.4K
HUSN
3980
DELISTED
Hudson Capital Inc. Ordinary Shares
HUSN
$28K ﹤0.01%
14,675
+4,312
+42% +$16.1K
AMST icon
3981
Amesite
AMST
$7.01M
$27K ﹤0.01%
3,992
+2,984
+296% +$27.6K
PRFX icon
3982
PRF Technologies Ltd
PRFX
$3.65M
$27K ﹤0.01%
18
+6
+50% +$8.41K
PZG icon
3983
Paramount Gold Nevada
PZG
$127M
$27K ﹤0.01%
42,000
-42,200
-50% -$29.4K
PHCF
3984
DELISTED
Puhui Wealth Investment Management Co., Ltd.
PHCF
$27K ﹤0.01%
5,150
+2,167
+73% +$13.2K
NVIV
3985
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$27K ﹤0.01%
3,172
+1,916
+153% +$18.2K
INUV icon
3986
Inuvo
INUV
$14.2M
$26K ﹤0.01%
5,240
+1,570
+43% +$7.26K
SNGX icon
3987
Soligenix
SNGX
$8.29M
$26K ﹤0.01%
151
+59
+64% +$9.48K
MOTS
3988
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$26K ﹤0.01%
+245
New +$28.6K
GET
3989
DELISTED
Getnet Adquirencia e Servicos para Meios de Pagamento S.A. American Depositary Shares
GET
$26K ﹤0.01%
+16,700
New +$22.2K
PTE
3990
DELISTED
PolarityTE, Inc. Common Stock
PTE
$26K ﹤0.01%
4,280
+972
+29% +$11.2K
DCOY
3991
Decoy Therapeutics
DCOY
$1.88M
$25K ﹤0.01%
2
-3
-60% -$47.3K
BAOS icon
3992
Baosheng Media Group
BAOS
$913K
$24K ﹤0.01%
2,167
-8,018
-79% -$109K
PME
3993
DELISTED
Pingtan Marine Enterprise Ltd.
PME
$24K ﹤0.01%
+37,900
New +$23.8K
PALI icon
3994
Palisade Bio
PALI
$375M
$23K ﹤0.01%
28
-80
-74% -$64.7K
XHG
3995
XChange TEC
XHG
$211M
$23K ﹤0.01%
1
-1
-50% -$32.8K
TLIS
3996
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$23K ﹤0.01%
+1,107
New +$38.3K
SVRA icon
3997
Savara
SVRA
$1.08B
$22K ﹤0.01%
16,700
-327,792
-95% -$395K
BGM
3998
BGM Group Ltd
BGM
$5.97M
$22K ﹤0.01%
2,610
+50
+2% +$516
HURA
3999
TuHURA Biosciences
HURA
$146M
$22K ﹤0.01%
31
-85
-73% -$61.2K
BIOL
4000
DELISTED
Biolase, Inc.
BIOL
$22K ﹤0.01%
25
+10
+67% +$9.22K

Similar funds

Jim Simons's Q1 2022 Portfolio in Review

As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.

  • Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
  • Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
  • Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
  • Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
  • Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
  • Jim Simons opened 822 new positions and closed 650 in Q1 2022.
  • Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.